Homo sapiens
A172 treated with 150 micromoles for 2 weeks (72 hours treatment, 96 hours rest, 2 times) biological replicate
ENA first public
2026-07-08
INSDC center name
LUHS
INSDC status
public
Submitter Id
A172_T3
cancer_type
Glioblastoma
cell_line
A172
collection date
2025-03-06
common name
human
geographic location (country and/or sea)
Lithuania
sample name
A172_T3
scientific_name
Homo sapiens
treatment_type
temozolomide